This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Join BioNTech AG at TIDES Digital Week 2020

Webinar: Individualized Neoantigen-Specific Therapy Against Cancer Using Messenger RNA (June 3 at 11am EST)

One of the obviously biggest challenges in fighting cancer is that every patient has a unique cancer. One reasonable approach to overcome this is to target the unique molecular signature of each cancer and to adapt treatment to the patient’s disease and immune system dynamics. To deliver the genetic information of antigens into antigen-presenting dendritic cells of the immune system the mRNA platform technology offers plenty of new options. The presentation will deal with conducting a clinical trial with a neoantigen-specific therapy using mRNA.

BioNTech will also be speaking at TIDES US in Boston, September 15-18

Session: Manufacturing and CMC Approaches to mRNA Therapeutics

Register today using code BIONTECH for 10% off your conference pass